CATX Stock-Based Compensation
Perspective Therapeutics Inc · Stock-Based Compensation
CATX Stock-Based Compensation
Latest reported$10.06Mperiod ending
CATX TTM Stock-Based Comp ($0.00 → $10.06M)
TTM stock-based compensation
High-resolution chart · PNG
CATX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 10,064,000 | |
| 9,421,000 | |
| 8,966,000 | |
| 8,717,000 | |
| 8,513,000 | |
| 6,829,000 | |
| 5,387,000 | |
| 4,047,000 | |
| 2,546,000 | |
| 3,026,000 | |
| 3,738,000 | |
| 3,018,000 | |
| 3,032,000 | |
| 1,987,000 | |
| 776,000 | |
| 956,000 | |
| 1,087,000 | |
| 1,059,000 | |
| 996,000 | |
| 897,000 | |
| 386,000 | |
| 479,000 | |
| 476,000 | |
| 489,000 | |
| 495,000 | |
| 427,000 | |
| 415,000 | |
| 418,000 | |
| 420,000 | |
| 559,000 | |
| 557,000 | |
| 610,000 | |
| 607,000 | |
| 527,000 | |
| 490,000 | |
| 392,000 | |
| 372,000 | |
| 222,870 | |
| 348,870 | |
| 327,870 | |
| 289,870 | |
| 369,904 | |
| 225,357 | |
| 215,811 | |
| 205,264 | |
| 185,130 | |
| 177,108 | |
| 169,087 | |
| 185,987 | |
| 88,199 | |
| 102,348 | |
| 117,741 | |
| 108,351 | |
| 159,124 | |
| 164,733 | |
| 169,097 | |
| 173,323 | |
| 273,635 | |
| 260,818 | |
| 251,286 | |
| 242,689 | |
| 226,370 | |
| 240,806 | |
| 239,698 | |
| 273,033 | |
| 213,531 | |
| 234,391 | |
| 211,841 | |
| 153,914 | |
| 55,668 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |